Literature DB >> 12481397

[Dysarthria during irinotecan administration].

B Ceccaldi, F Kara, H Mommeja-Marin, M Bègue, P Saint Blancard, E Le Marec, D Hauteville.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12481397     DOI： 10.1016/s0248-8663(02)00707-5

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN： 0248-8663            Impact factor:   0.728


× No keyword cloud information.
  2 in total

1.  FOLFIRINOX-induced reversible dysarthria: A case report and review of previous cases.

Authors:  Ayumu Matsuoka; Osamu Maeda; Megumi Inada-Inoue; Eizaburo Ohno; Yoshiki Hirooka; Yukihiro Yokoyama; Tsutomu Fujii; Masato Nagino; Hidemi Goto; Yuichi Ando
Journal:  Oncol Lett       Date:  2015-08-11       Impact factor: 2.967

2.  Irinotecan-induced dysarthria: an insight into its pathogenesis?

Authors:  Jesus A Gomez; Ines Sanchez; Jose A Ramirez
Journal:  Gastrointest Cancer Res       Date:  2008-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.